These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 23017140)

  • 1. Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development.
    Kohanbash G; Okada H
    Immunol Invest; 2012; 41(6-7):658-79. PubMed ID: 23017140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF promotes the immunosuppressive activity of glioma-infiltrating myeloid cells through interleukin-4 receptor-α.
    Kohanbash G; McKaveney K; Sakaki M; Ueda R; Mintz AH; Amankulor N; Fujita M; Ohlfest JR; Okada H
    Cancer Res; 2013 Nov; 73(21):6413-23. PubMed ID: 24030977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-derived suppressor cells and anti-tumor T cells: a complex relationship.
    Monu NR; Frey AB
    Immunol Invest; 2012; 41(6-7):595-613. PubMed ID: 23017137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PGE(2)-driven induction and maintenance of cancer-associated myeloid-derived suppressor cells.
    Obermajer N; Wong JL; Edwards RP; Odunsi K; Moysich K; Kalinski P
    Immunol Invest; 2012; 41(6-7):635-57. PubMed ID: 23017139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune suppression: the hallmark of myeloid derived suppressor cells.
    Haile LA; Greten TF; Korangy F
    Immunol Invest; 2012; 41(6-7):581-94. PubMed ID: 23017136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.
    Cohen PA; Ko JS; Storkus WJ; Spencer CD; Bradley JM; Gorman JE; McCurry DB; Zorro-Manrique S; Dominguez AL; Pathangey LB; Rayman PA; Rini BI; Gendler SJ; Finke JH
    Immunol Invest; 2012; 41(6-7):680-710. PubMed ID: 23017141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of polymorphonuclear myeloid-derived suppressor cells in patients with glioblastoma highly express S100A8/9 and arginase and suppress T cell function.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Bossman SA; Ter Laan M; Wesseling P; Adema GJ
    Neuro Oncol; 2016 Sep; 18(9):1253-64. PubMed ID: 27006175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative regulation of myeloid-derived suppressor cells in cancer.
    Qu P; Boelte KC; Lin PC
    Immunol Invest; 2012; 41(6-7):562-80. PubMed ID: 23017135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment.
    Mi Y; Guo N; Luan J; Cheng J; Hu Z; Jiang P; Jin W; Gao X
    Front Immunol; 2020; 11():737. PubMed ID: 32391020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Insights into the Multifaceted Role of Myeloid-Derived Suppressor Cells (MDSCs) in High-Grade Gliomas: From Metabolic Reprograming, Immunosuppression, and Therapeutic Resistance to Current Strategies for Targeting MDSCs.
    Lakshmanachetty S; Cruz-Cruz J; Hoffmeyer E; Cole AP; Mitra SS
    Cells; 2021 Apr; 10(4):. PubMed ID: 33919732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid derived suppressor cell infiltration of murine and human gliomas is associated with reduction of tumor infiltrating lymphocytes.
    Raychaudhuri B; Rayman P; Huang P; Grabowski M; Hambardzumyan D; Finke JH; Vogelbaum MA
    J Neurooncol; 2015 Apr; 122(2):293-301. PubMed ID: 25579983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myeloid derived suppressor cells and their role in diseases.
    Kong YY; Fuchsberger M; Xiang SD; Apostolopoulos V; Plebanski M
    Curr Med Chem; 2013; 20(11):1437-44. PubMed ID: 23409714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of L-arginine by myeloid-derived suppressor cells in cancer: mechanisms of T cell suppression and therapeutic perspectives.
    Raber P; Ochoa AC; Rodríguez PC
    Immunol Invest; 2012; 41(6-7):614-34. PubMed ID: 23017138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
    Kamran N; Kadiyala P; Saxena M; Candolfi M; Li Y; Moreno-Ayala MA; Raja N; Shah D; Lowenstein PR; Castro MG
    Mol Ther; 2017 Jan; 25(1):232-248. PubMed ID: 28129117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycyrrhizic acid-mediated subdual of myeloid-derived suppressor cells induces antileishmanial immune responses in a susceptible host.
    Bandyopadhyay S; Bhattacharjee A; Banerjee S; Halder K; Das S; Paul Chowdhury B; Majumdar S
    Infect Immun; 2015 Dec; 83(12):4476-86. PubMed ID: 26351281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.
    Alghamri MS; Kamran N; Kadiyala P; Lowenstein PR; Castro MG
    Methods Enzymol; 2020; 632():215-228. PubMed ID: 32000897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypotheses.
    Solito S; Pinton L; Damuzzo V; Mandruzzato S
    Immunol Invest; 2012; 41(6-7):722-37. PubMed ID: 23017143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives.
    Rodríguez PC; Ochoa AC
    Immunol Rev; 2008 Apr; 222():180-91. PubMed ID: 18364002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid-derived suppressor cell function is diminished in aspirin-triggered allergic airway hyperresponsiveness in mice.
    Shi M; Shi G; Tang J; Kong D; Bao Y; Xiao B; Zuo C; Wang T; Wang Q; Shen Y; Wang H; Funk CD; Zhou J; Yu Y
    J Allergy Clin Immunol; 2014 Nov; 134(5):1163-74.e16. PubMed ID: 24948368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.